Background: People living with human immunodeficiency virus (PLHIV) are approximately
twice as likely to be depressed compared with HIV-negative individuals. Depression is …

Most measures of adherence to antiretroviral therapy require a blood sample, and none
capture longitudinal daily adherence. A new noninvasive method for measuring daily …

HAART has increased the life expectancy of HIV-infected individuals significantly. Optimal
adherence to HAART results in viral suppression and immune recovery in the majority of HIV …

Food insecurity is associated with HIV treatment non-adherence and poor health outcomes
for people living with HIV/AIDS. Given the poor nutritional status common to people who …

Clinical trials including an analytical treatment interruption (ATI) are vital for evaluating the
efficacy of novel strategies for HIV remissions. We briefly describe an interactive tool for …

Background Despite advances in treatment of people living with HIV, morbidity and mortality
remains unacceptably high in sub-Saharan Africa, largely due to parallel epidemics of …

Antiretroviral therapy for the treatment of HIV infection requires high levels of adherence to
both maintain plasma HIV RNA at undetectable levels and prevent the emergence of drug …

Objective To assess the effects of facility-based interventions using existing resources to
improve overall patient attendance and adherence to antiretroviral therapy (ART) at ART …

Background: Racial and ethnic disparities in antiretroviral therapy (ART) adherence and
sustained viral suppression (SVS) have been documented among women with HIV. We …

Phone-based unannounced pill counts to measure medication adherence are much more
practical and less expensive than home-based unannounced pill counts, but their validity …